These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17707686)

  • 1. Antibacterial targets in fatty acid biosynthesis.
    Wright HT; Reynolds KA
    Curr Opin Microbiol; 2007 Oct; 10(5):447-53. PubMed ID: 17707686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery.
    Campbell JW; Cronan JE
    Annu Rev Microbiol; 2001; 55():305-32. PubMed ID: 11544358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reductase steps of the type II fatty acid synthase as antimicrobial targets.
    Zhang YM; Lu YJ; Rock CO
    Lipids; 2004 Nov; 39(11):1055-60. PubMed ID: 15726819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid biosynthesis as a target for antibacterial agents.
    Heath RJ; White SW; Rock CO
    Prog Lipid Res; 2001 Nov; 40(6):467-97. PubMed ID: 11591436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic signature of fatty acid biosynthesis inhibition available for in vivo mechanism-of-action studies.
    Wenzel M; Patra M; Albrecht D; Chen DY; Nicolaou KC; Metzler-Nolte N; Bandow JE
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2590-6. PubMed ID: 21383089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial fatty acid metabolism in modern antibiotic discovery.
    Yao J; Rock CO
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Nov; 1862(11):1300-1309. PubMed ID: 27668701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of bacterial fatty acid biosynthetic enzymes as a source of novel antibacterial agents.
    Payne DJ
    Drug News Perspect; 2004 Apr; 17(3):187-94. PubMed ID: 15179453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of bacterial fatty acid synthase inhibitors from a Phoma species as antimicrobial agents using a new antisense-based strategy.
    Ondeyka JG; Zink DL; Young K; Painter R; Kodali S; Galgoci A; Collado J; Tormo JR; Basilio A; Vicente F; Wang J; Singh SB
    J Nat Prod; 2006 Mar; 69(3):377-80. PubMed ID: 16562839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of Platensimycin and Platencin: Inhibitors of β-Ketoacyl-acyl Carrier Protein (ACP) Synthase III (FabH).
    Shang R; Liang J; Yi Y; Liu Y; Wang J
    Molecules; 2015 Sep; 20(9):16127-41. PubMed ID: 26404223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of fatty acid synthesis as antimicrobial chemotherapeutics.
    Heath RJ; White SW; Rock CO
    Appl Microbiol Biotechnol; 2002 May; 58(6):695-703. PubMed ID: 12021787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting bacterial fatty acid synthesis.
    Zhang YM; White SW; Rock CO
    J Biol Chem; 2006 Jun; 281(26):17541-4. PubMed ID: 16648134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents.
    Wang Y; Ma S
    ChemMedChem; 2013 Oct; 8(10):1589-608. PubMed ID: 23894064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platensimycin and platencin: promising antibiotics for future application in human medicine.
    Martens E; Demain AL
    J Antibiot (Tokyo); 2011 Nov; 64(11):705-10. PubMed ID: 21915133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.
    Nie Z; Perretta C; Lu J; Su Y; Margosiak S; Gajiwala KS; Cortez J; Nikulin V; Yager KM; Appelt K; Chu S
    J Med Chem; 2005 Mar; 48(5):1596-609. PubMed ID: 15743201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the assembly of bacterial cell division protein FtsZ with small molecules.
    Schaffner-Barbero C; Martín-Fontecha M; Chacón P; Andreu JM
    ACS Chem Biol; 2012 Feb; 7(2):269-77. PubMed ID: 22047077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fatty acid synthesis by the antibiotic thiolactomycin.
    Hayashi T; Yamamoto O; Sasaki H; Okazaki H; Kawaguchi A
    J Antibiot (Tokyo); 1984 Nov; 37(11):1456-61. PubMed ID: 6511668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crucial components of Mycobacterium type II fatty acid biosynthesis (Fas-II) and their inhibitors.
    Duan X; Xiang X; Xie J
    FEMS Microbiol Lett; 2014 Nov; 360(2):87-99. PubMed ID: 25227413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the fungal fatty acid synthase type I multienzyme complex.
    Johansson P; Wiltschi B; Kumari P; Kessler B; Vonrhein C; Vonck J; Oesterhelt D; Grininger M
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12803-8. PubMed ID: 18725634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel FabH inhibitors: an updated article literature review (July 2012 to June 2013).
    Song H; Ao GZ; Li HQ
    Expert Opin Ther Pat; 2014 Jan; 24(1):19-27. PubMed ID: 24083428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.